About the GMO tables
The following tables provide a summary of GMOs released into the environment.
GMOs can be released for a limited time under specified conditions (limited and controlled release) or without a time limit on their release (“Commercial release”). Some restrictions on commercial releases may still apply.
All releases are assigned a licence number and referred to as “DIR” which is short for “Dealings involving intentional release” into the environment. “Dealing” with GMO includes many activities such as conduct experiments, make, develop, produce, transport and dispose.
In addition to licences, there is also a “GMO Register”. The Regulator can decide that certain dealings previously authorised by a licence may be included in the GMO Register. Dealings on the GMO register no longer require a licence, they can be conducted by anyone.
6 entries found
|Licence No||Organisation||Title of Project||Parent Organism||Modified Trait||Issue Date||Licence Status|
|DIR 180||AstraZeneca Pty Ltd||Commercial supply of a genetically modified COVID-19 vaccine||Application under evaluation|
|DIR 179||Novotech (Australia) Pty Limited||Clinical trial with a genetically modified Vaccinia virus vaccine to treat solid cancerous tumours||Application under evaluation|
|DIR 177||Novotech (Australia) Pty Limited||Clinical trial of genetically modified human adenovirus for bladder cancer treatment||Application under evaluation|
|DIR 176||PTM Solutions Australia Pty Ltd||Limited and controlled release of white clover genetically modified for increased condensed tannins||Application under evaluation|
|DIR 175||BASF Australia Ltd||Commercial release of canola (Brassica napus) genetically modified for herbicide tolerance and a hybrid breeding system (MS11)||Application under evaluation|
|DIR 174||Biocelect Pty Ltd||Commercial supply of a genetically modified cholera vaccine, VaxchoraŽ||Application under evaluation|